πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 650 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8648072

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders,

Jenrin Discovery, LLC Β· Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8636997

Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8628764

Biocontrol of storage maladies of potatoes by bacterial antagonists produced in co-culture

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8629141

Spiro-oxindole MDM2 antagonists

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8617530

Polymer conjugates of opioid antagonists

Nektar Therapeutics Β· Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8609395

Agonist and antagonist peptides of carcinoembryonic antigen (CEA)

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8598149

Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders

Corcept Therapeutics Incorporated Β· Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8592402

Compounds as lysophosphatidic acid receptor antagonists

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8592453

Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580768

Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders,

Jenrin Discovery, LLC Β· Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8569351

Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor an

Theravance, Inc. Β· Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8557997

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8557245

Methods for treating bone cancer by administering a nerve growth factor antagonist antibod

Regents of the University of Minnesota Β· Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8551978

Diamide compounds having muscarinic receptor antagonist and Ξ²2 adrenergic receptor agonist

Theravance, Inc. Β· Granted Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8541587

Lysophosphatidic acid receptor antagonists

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8524748

Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8518984

Spiro-oxindole MDM2 antagonists

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8518887

Method of treating cancer with DLL4 antagonist and chemotherapeutic agent

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8518966

Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance, Inc. Β· Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8507536

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8501959

Cycloalkane[B]indole antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8501776

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8497287

Aminotetralin compounds as mu opioid receptor antagonists

Theravance, Inc. Β· Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8497381

Antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted